vs
Side-by-side financial comparison of Opus Genetics, Inc. (IRD) and Worksport Ltd (WKSP). Click either name above to swap in a different company.
Worksport Ltd is the larger business by last-quarter revenue ($4.7M vs $3.9M, roughly 1.2× Opus Genetics, Inc.). On growth, Worksport Ltd posted the faster year-over-year revenue change (62.0% vs -10.2%). Over the past eight quarters, Worksport Ltd's revenue compounded faster (204.2% CAGR vs 50.3%).
Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.
Worksport LtdWKSPEarnings & Financial Report
Worksport Ltd is a cleantech company specializing in portable solar energy solutions and custom truck bed accessories. Its core offerings include solar-powered tonneau covers for pickup trucks and portable mobile power stations, serving the North American automotive aftermarket and consumer clean energy segments.
IRD vs WKSP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.9M | $4.7M |
| Net Profit | — | — |
| Gross Margin | — | 30.1% |
| Operating Margin | — | -129.6% |
| Net Margin | — | — |
| Revenue YoY | -10.2% | 62.0% |
| Net Profit YoY | 53.0% | — |
| EPS (diluted) | — | $-0.65 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.9M | $4.7M | ||
| Q3 25 | $3.1M | $5.0M | ||
| Q2 25 | $2.9M | $4.1M | ||
| Q1 25 | $4.4M | $2.2M | ||
| Q4 24 | $4.3M | $2.9M | ||
| Q3 24 | $3.9M | $3.1M | ||
| Q2 24 | $1.1M | $1.9M | ||
| Q1 24 | $1.7M | $512.6K |
| Q4 25 | — | — | ||
| Q3 25 | $-17.5M | $-4.9M | ||
| Q2 25 | $-7.4M | $-3.7M | ||
| Q1 25 | $-8.2M | $-4.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-7.5M | $-4.1M | ||
| Q2 24 | $-7.8M | $-4.0M | ||
| Q1 24 | $-7.1M | $-3.7M |
| Q4 25 | — | 30.1% | ||
| Q3 25 | — | 31.3% | ||
| Q2 25 | — | 26.4% | ||
| Q1 25 | — | 17.7% | ||
| Q4 24 | — | 11.1% | ||
| Q3 24 | — | 7.9% | ||
| Q2 24 | — | 15.4% | ||
| Q1 24 | — | 7.3% |
| Q4 25 | — | -129.6% | ||
| Q3 25 | -269.9% | -95.6% | ||
| Q2 25 | -309.0% | -88.1% | ||
| Q1 25 | -227.2% | -190.0% | ||
| Q4 24 | — | -137.0% | ||
| Q3 24 | -207.1% | -125.1% | ||
| Q2 24 | -748.9% | -203.5% | ||
| Q1 24 | -450.5% | -709.9% |
| Q4 25 | — | — | ||
| Q3 25 | -566.9% | -98.3% | ||
| Q2 25 | -257.5% | -91.0% | ||
| Q1 25 | -187.5% | -199.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | -194.6% | -132.4% | ||
| Q2 24 | -698.3% | -208.9% | ||
| Q1 24 | -415.3% | -724.6% |
| Q4 25 | — | $-0.65 | ||
| Q3 25 | $-0.25 | $-0.75 | ||
| Q2 25 | $-0.12 | $-0.71 | ||
| Q1 25 | $-0.24 | $-1.05 | ||
| Q4 24 | — | $-1.14 | ||
| Q3 24 | $-0.29 | $-1.40 | ||
| Q2 24 | $-0.30 | $-1.55 | ||
| Q1 24 | $-0.29 | $-1.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $45.1M | $5.9M |
| Total DebtLower is stronger | — | $2.7M |
| Stockholders' EquityBook value | $15.3M | $22.9M |
| Total Assets | $50.2M | $30.7M |
| Debt / EquityLower = less leverage | — | 0.12× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.1M | $5.9M | ||
| Q3 25 | $30.8M | $3.8M | ||
| Q2 25 | $32.4M | $1.4M | ||
| Q1 25 | $41.8M | $5.1M | ||
| Q4 24 | $30.3M | $4.9M | ||
| Q3 24 | $36.6M | $1.9M | ||
| Q2 24 | $41.4M | $3.4M | ||
| Q1 24 | $47.2M | $3.5M |
| Q4 25 | — | $2.7M | ||
| Q3 25 | — | $2.9M | ||
| Q2 25 | — | $2.5M | ||
| Q1 25 | — | $3.1M | ||
| Q4 24 | — | $5.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $15.3M | $22.9M | ||
| Q3 25 | $6.0M | $19.8M | ||
| Q2 25 | $17.5M | $17.3M | ||
| Q1 25 | $5.1M | $20.1M | ||
| Q4 24 | $6.7M | $17.4M | ||
| Q3 24 | $34.3M | $16.4M | ||
| Q2 24 | $40.6M | $19.1M | ||
| Q1 24 | $46.1M | $18.9M |
| Q4 25 | $50.2M | $30.7M | ||
| Q3 25 | $36.1M | $27.0M | ||
| Q2 25 | $38.7M | $23.6M | ||
| Q1 25 | $48.2M | $26.7M | ||
| Q4 24 | $36.9M | $25.7M | ||
| Q3 24 | $40.4M | $24.9M | ||
| Q2 24 | $44.8M | $27.2M | ||
| Q1 24 | $51.8M | $27.3M |
| Q4 25 | — | 0.12× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.14× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.30× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-35.3M | $-6.1M |
| Free Cash FlowOCF − Capex | — | $-6.3M |
| FCF MarginFCF / Revenue | — | -132.4% |
| Capex IntensityCapex / Revenue | — | 3.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-18.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-35.3M | $-6.1M | ||
| Q3 25 | $-6.2M | $-4.3M | ||
| Q2 25 | $-10.3M | $-3.1M | ||
| Q1 25 | $-9.0M | $-3.8M | ||
| Q4 24 | $-25.6M | $-2.2M | ||
| Q3 24 | $-5.1M | $-1.5M | ||
| Q2 24 | $-7.3M | $-3.6M | ||
| Q1 24 | $-5.7M | $-2.8M |
| Q4 25 | — | $-6.3M | ||
| Q3 25 | — | $-4.6M | ||
| Q2 25 | — | $-3.2M | ||
| Q1 25 | — | $-4.0M | ||
| Q4 24 | — | $-2.2M | ||
| Q3 24 | — | $-1.7M | ||
| Q2 24 | — | $-3.7M | ||
| Q1 24 | — | $-3.0M |
| Q4 25 | — | -132.4% | ||
| Q3 25 | — | -92.1% | ||
| Q2 25 | — | -77.1% | ||
| Q1 25 | — | -180.4% | ||
| Q4 24 | — | -75.4% | ||
| Q3 24 | — | -54.5% | ||
| Q2 24 | — | -195.1% | ||
| Q1 24 | — | -586.7% |
| Q4 25 | — | 3.3% | ||
| Q3 25 | — | 7.3% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 9.0% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | — | 5.3% | ||
| Q2 24 | — | 6.4% | ||
| Q1 24 | — | 41.5% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
